`
`Filed on behalf of: Mylan Pharmaceuticals, Inc.
`By:
`Steven W. Parmelee
`Michael T. Rosato
`
`WILSON SONSINI GOODRICH & ROSATI
`
`701 Fifth Avenue, Suite 5100
`
`Seattle, WA 98104-7036
`Tel.: 206-883-2542
`
`Fax: 206-883-2699
`
`Email: sparmelee@Wsgr.com
`Email: rnr0sato@wsgr.com
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`NOVEN PHARMACEUTICALS, INC. and MYLAN
`PHARMACEUTICALS, INC.,
`Petitioners,
`
`V.
`
`NOVARTIS AG and LTS LOHMANN THERAPIE-SYSTEME
`
`AG,
`Patent Owner.
`
`Case IPR20l4-00549
`
`Patent No. 6,316,023
`
`PETITIONER MYLAN PHARMACEUTICALS, INC.’S
`
`POWER OF ATTORNEY
`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Petitioner, Mylan Pharmaceuticals, Inc.,
`
`hereby revokes all previous powers of attorney associated with this inter partes
`
`review proceeding and appoints the practitioners associated with Wilson Sonsini
`
`Goodrich & Rosati, Customer Number 21971, including the following lead and
`
`back—up counsel, as its attorneys to transact all business in the United States Patent
`
`& Trademark Office associated with a petition for inter partes review of U.S.
`
`Patent No. 6,316,023:
`
`Lead Counsel
`
`1
`
`Back-Up Counsel
`
`Steven W. Parmelee
`
`Michael T. Rosato
`
`USPTO Reg. No. 52,182
`USPTO Reg. No. 31,990
`WILSON SONSINI GOODRICH WILSON SONSINI GOODRICH
`
`& ROSATI
`
`& ROSATI
`
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`Tel.: 206-883-2542
`
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`Tel.: 206-883-2529
`
`Fax: 206-883-2699
`
`Fax: 206-883-2699
`
`Email: sparmelee@wsgr.com
`
`Email: mrosato@wsgr.com
`
`
`
`Name: :57: 2/gm!
`
`I6’. F<>"r‘~’-3"!’
`
`Title: V2015 F’£&5/i>e:;é'i’i ztsxip
`/€326-,:cA~r5
`(_:L.x,;i,!et,:«_:-xx, ec».x_,g5ez:-
`
`Date:
`
`;’Vo‘w,E”:::
`
`.1»; 0, 2025